This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ethris Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Inventor Profile: Kai Wohlgemuth
Introduction
Kai Wohlgemuth is an innovative inventor based in Drensteinfurt, Germany. He is currently associated with Ethris GmbH, where he contributes to advancements in pharmaceutical compositions. Although he has not yet been granted any patents, his work focuses on significant medical applications.
Latest Patent Applications
Wohlgemuth's notable patent application is titled "Treatment of Ciliopathies." This application presents a pharmaceutical composition that includes a polyribonucleotide aimed at treating ciliopathies in affected subjects. The polyribonucleotide encodes a functional version of a protein whose defect is linked to the ciliopathy. The application emphasizes the administration of this composition to the respiratory system, particularly when the subject exhibits respiratory inflammation. Additionally, the application outlines a method for analyzing the effects of the polyribonucleotide on ciliogenesis, highlighting its role in the process.
Conclusion
Kai Wohlgemuth is a promising inventor whose work at Ethris GmbH is paving the way for innovative treatments in the field of ciliopathies. His contributions, although not yet reflected in granted patents, hold potential for significant advancements in medical science.